SBI Securities
FTH icon

SBI Securities’s Faeth Therapeutics FTH Stock Holding History

SBI Securities’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$119 Hold
4
– – ﹤0.01% 3542
2026
Q2 		$100 Hold
4
– – ﹤0.01% 3512
2026
Q1 		$126 Hold
4
– – ﹤0.01% 3357
2025
Q4 		$43 Sell
4
-145
-97% -$1.4K ﹤0.01% 3607
2025
Q3 		$1.41K Hold
149
– – ﹤0.01% 2558
2025
Q2 		$1.28K Buy
149
+144
+2,880% +$1.03K ﹤0.01% 2569
2025
Q1 		$36 Buy
5
+1
+25% +$10 ﹤0.01% 3734
2024
Q4 		$35 Buy
+4
New +$40 ﹤0.01% 3712

Other funds holding FTH

Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
RIS
Richmond Investment Services Mequon, Wisconsin $316M AUM 19.72% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Financial Consulate
Financial Consulate Hunt Valley, Maryland $899M AUM 14.82% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

SBI Securities's FTH Position: Q3 2026 in Review

SBI Securities held its Faeth Therapeutics (FTH) position steady in Q3 2026 at 4 shares worth $119. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

SBI Securities first reported a position in FTH in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.41K in Q3 2025. 9 funds tracked by Wall St. Rank hold FTH as of Q3 2026.

  • SBI Securities held 4 shares of Faeth Therapeutics worth $119 as of Q3 2026.
  • SBI Securities left its Faeth Therapeutics share count unchanged in Q3 2026.
  • Faeth Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3542 holding.
  • SBI Securities first reported a position in Faeth Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Faeth Therapeutics position peaked at $1.41K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.